186 related articles for article (PubMed ID: 37434463)
1. Efficacy of melatonin and ramelteon for the acute and long-term management of insomnia disorder in adults: A systematic review and meta-analysis.
Maruani J; Reynaud E; Chambe J; Palagini L; Bourgin P; Geoffroy PA
J Sleep Res; 2023 Dec; 32(6):e13939. PubMed ID: 37434463
[TBL] [Abstract][Full Text] [Related]
2. Ramelteon for the treatment of insomnia in adults: a systematic review and meta-analysis.
Kuriyama A; Honda M; Hayashino Y
Sleep Med; 2014 Apr; 15(4):385-92. PubMed ID: 24656909
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of ramelteon for insomnia symptoms in older adults with obstructive sleep apnea: a randomized placebo-controlled pilot study.
Gooneratne NS; Gehrman P; Gurubhagavatula I; Al-Shehabi E; Marie E; Schwab R
J Clin Sleep Med; 2010 Dec; 6(6):572-80. PubMed ID: 21206546
[TBL] [Abstract][Full Text] [Related]
4. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty.
Mini LJ; Wang-Weigand S; Zhang J
Am J Geriatr Pharmacother; 2007 Sep; 5(3):177-84. PubMed ID: 17996657
[TBL] [Abstract][Full Text] [Related]
5. Ramelteon for the treatment of insomnia.
Borja NL; Daniel KL
Clin Ther; 2006 Oct; 28(10):1540-55. PubMed ID: 17157111
[TBL] [Abstract][Full Text] [Related]
6. Ramelteon 8 mg/d versus placebo in patients with chronic insomnia: post hoc analysis of a 5-week trial using 50% or greater reduction in latency to persistent sleep as a measure of treatment effect.
Mini L; Wang-Weigand S; Zhang J
Clin Ther; 2008 Jul; 30(7):1316-23. PubMed ID: 18691991
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapies for sleep disturbances in dementia.
McCleery J; Cohen DA; Sharpley AL
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD009178. PubMed ID: 27851868
[TBL] [Abstract][Full Text] [Related]
8. Effects of ramelteon 8 mg on objective sleep latency in adults with chronic insomnia on nights 1 and 2: pooled analysis.
Wang-Weigand S; McCue M; Ogrinc F; Mini L
Curr Med Res Opin; 2009 May; 25(5):1209-13. PubMed ID: 19327100
[TBL] [Abstract][Full Text] [Related]
9. A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia.
Roth T; Seiden D; Wang-Weigand S; Zhang J
Curr Med Res Opin; 2007 May; 23(5):1005-14. PubMed ID: 17519067
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia.
Mayer G; Wang-Weigand S; Roth-Schechter B; Lehmann R; Staner C; Partinen M
Sleep; 2009 Mar; 32(3):351-60. PubMed ID: 19294955
[TBL] [Abstract][Full Text] [Related]
11. Searching for new options for treating insomnia: are melatonin and ramelteon beneficial?
Bellon A
J Psychiatr Pract; 2006 Jul; 12(4):229-43. PubMed ID: 16883148
[TBL] [Abstract][Full Text] [Related]
12. Use of a post-sleep questionnaire-interactive voice response system (PSQ-IVRS) to evaluate the subjective sleep effects of ramelteon in adults with chronic insomnia.
Wang-Weigand S; Watissée M; Roth T
Sleep Med; 2011 Oct; 12(9):920-3. PubMed ID: 21925941
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapies for sleep disturbances in Alzheimer's disease.
McCleery J; Cohen DA; Sharpley AL
Cochrane Database Syst Rev; 2014 Mar; (3):CD009178. PubMed ID: 24659320
[TBL] [Abstract][Full Text] [Related]
14. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
Roth T; Seiden D; Sainati S; Wang-Weigand S; Zhang J; Zee P
Sleep Med; 2006 Jun; 7(4):312-8. PubMed ID: 16709464
[TBL] [Abstract][Full Text] [Related]
15. Ramelteon: a novel approach in the treatment of insomnia.
Reynoldson JN; Elliott E; Nelson LA
Ann Pharmacother; 2008 Sep; 42(9):1262-71. PubMed ID: 18648020
[TBL] [Abstract][Full Text] [Related]
16. Safety and subjective sleep effects of ramelteon administration in adults and older adults with chronic primary insomnia: a 1-year, open-label study.
Richardson GS; Zammit G; Wang-Weigand S; Zhang J
J Clin Psychiatry; 2009 Apr; 70(4):467-76. PubMed ID: 19284927
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of subjective efficacy and safety of ramelteon in Japanese subjects with chronic insomnia.
Uchiyama M; Hamamura M; Kuwano T; Nishiyama H; Nagata H; Uchimura N
Sleep Med; 2011 Feb; 12(2):119-26. PubMed ID: 21256803
[TBL] [Abstract][Full Text] [Related]
18. The effects of ramelteon in a first-night model of transient insomnia.
Zammit G; Schwartz H; Roth T; Wang-Weigand S; Sainati S; Zhang J
Sleep Med; 2009 Jan; 10(1):55-9. PubMed ID: 18691937
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis.
De Crescenzo F; D'Alò GL; Ostinelli EG; Ciabattini M; Di Franco V; Watanabe N; Kurtulmus A; Tomlinson A; Mitrova Z; Foti F; Del Giovane C; Quested DJ; Cowen PJ; Barbui C; Amato L; Efthimiou O; Cipriani A
Lancet; 2022 Jul; 400(10347):170-184. PubMed ID: 35843245
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of ramelteon in Japanese adults with chronic insomnia: a randomized, double-blind, placebo-controlled study.
Uchimura N; Ogawa A; Hamamura M; Hashimoto T; Nagata H; Uchiyama M
Expert Rev Neurother; 2011 Feb; 11(2):215-24. PubMed ID: 21306209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
